IFNAR1 and obesity due to melanocortin 4 receptor deficiency: Despite similar body weight, Adipoqcre IFNAR deletion did impact obesity-associated glucose dysmetabolism (Fig. 6g), without modulating liver triglyceride levels (Fig. 6h) or hepatocellular damage (Fig. 6i).